StockpollyBeta
Get App
Popularity #724
CTVA · NYSE · Agricultural Inputs

Corteva (CTVA)

Develops seed genetics and crop-protection products for farmers worldwide.

$79.94
vs last close+0.83 (+1.05%)
Loading prices…

Something off on this page? Send us feedback.

Corteva, Inc.CTVA
Materials

Develops seed genetics and crop-protection products, earning revenue from seed and trait sales, licensing, herbicides, insecticides, fungicides and biologicals worldwide. A planned separation would spin Seed into Vylor and leave CTVA focused on Crop Protection.

Develops commercial seed and crop-protection products through two operating segments. Seed combines proprietary germplasm and traits for corn, soybeans, canola, cotton, sunflower and other crops, marketed through brands including Pioneer, Brevant and PhytoGen and through trait licensing. Crop Protection supplies herbicides, insecticides, fungicides, biologicals and nitrogen stabilizers, including Enlist, Arylex, Rinskor and Zorvec technologies.

Pairs genetics and chemistry research with direct farmer relationships, distributors and region-specific seed routes to market across North America, Latin America, Europe, the Middle East, Africa and Asia-Pacific. Demand and sales timing follow planting seasons, acreage, crop prices and weather, while commercialization depends on regulatory approvals and intellectual-property rights. A planned October separation would spin Seed into Vylor, leaving the CTVA-listed business focused on Crop Protection.

Company facts

CEOCharles V. Magro
ListedMay 24, 2019
ExchangeNYSE
HeadquartersIndianapolis, IN
CountryUnited States
Employees21,500
CIK0001755672
ISINUS22052L1044

Market cap$52.90B
EPS (ttm)$1.51
P/E (ttm)52.38
ROE4.1%
P/B2.10
P/S2.97
Dividend yieldDiv yield0.91%
Beta0.13vs XLB 0.92

Price target$95.00+20.1%Average of 37 analysts
ConsensusBuy23 of 37 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Sep 16, 2026BMO CapitalReiterate
Rating: —Target: $100
Rating: OutperformTarget: $95
Sep 16, 2026New StreetTarget
Target: —
Target: $95
Sep 16, 2026UBSReiterate
Rating: —Target: $86
Rating: NeutralTarget: $90
Sep 11, 2026KeyBancInitiate
Rating: —
Rating: Sector Weight
Aug 3, 2026Deutsche BankReiterate
Rating: —Target: $65
Rating: BuyTarget: $101

Next report
Nov 3, 26
in 42 days
EPS estimate
−$0.39
Revenue estimate
$2.65B
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$0.32$1.13$2.20−$0.23$0.22$1.50$2.30Pending
Estimate$0.31$0.87$1.89−$0.51$0.22$1.17$2.24−$0.39
Surprise+2.5%+29.3%+16.4%+54.6%−1.3%+28.2%+2.7%—

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$3.98B$4.42B$6.46B$2.62B$3.91B$4.91B$6.38BPending
Estimate$4.04B$4.54B$6.27B$2.47B$4.24B$4.64B$6.60B$2.65B
Surprise−1.5%−2.8%+3.0%+6.0%−7.8%+5.7%−3.3%—
Estimate−$0.39
ReportedDue Nov 3, 2026
Estimate$2.65B
ReportedDue Nov 3, 2026
View details

Debt to equity19.40%
Current ratio151.60%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$2.33B$3.98B$4.42B$6.46B$2.62B$3.91B$4.91B$6.38B
Net income−$524.0M−$41.0M$652.0M$1.31B−$320.0M−$552.0M$720.0M$1.16B
Net margin0.0%0.0%14.8%20.4%0.0%0.0%14.7%18.2%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income−$465.0M$327.0M$827.0M$1.83B−$270.0M$242.0M$1.16B$1.92B
YoY growthLoss widened+98.2%+18.7%+13.9%Loss narrowed−26.0%+39.7%+4.5%

Balance sheet, Jun 30, 2026Cash & short-term investments $2.37B · Total debt $4.88B · Total assets $41.64B · Shareholders' equity $25.16B

Revenue
$6.38B
Operating income
$1.92B
Net income
$1.16B
View details

Dividend yield
0.91%
Next ex-date
Dec 1, 26
estimated · in 70 days
Annual dividend
$0.72
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Dividend$0.17$0.17$0.17$0.18$0.18$0.18$0.18$0.18
Annual yield1.06%1.11%0.96%0.93%1.05%0.88%0.93%0.82%
Ex-dateDec 2Mar 3Jun 2Sep 2Dec 1Mar 2Jun 1Sep 1
Payment dateDec 16Mar 17Jun 16Sep 15Dec 15Mar 16Jun 15Sep 15
View details

Institutions89.01%598.58M shares
1,519 holders · as of Jun 30, 2026
Insiders0.18%1.21M shares
23 holders · as of Sep 17, 2026
Strategic holders8.89%59.76M shares
1 holder · as of Feb 7, 2022
Other1.92%12.98M shares
remainder

672.52M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This company has 2 share classes; every stake here is a share of the whole company.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Strategic
8.89%59.76Mfiled Feb 7, 2022
BlackRock, Inc.Institution
8.01%53.85Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
6.51%43.79Mas of Jun 30, 2026
Capital World InvestorsInstitution
6.38%42.92Mas of Jun 30, 2026
FMR LLCInstitution
6.11%41.07Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Feb 20, 2026Brian Titusofficer: See Remarks−8,311$76.55
View details

  • FMC

    Pure-play crop protection; diamide insecticide leader in head-to-head contest.

Compare

CompanyPriceChange
Corteva$79.94+1.05%$52.90B52.420.23.0−1.2%
FMC$10.47+1.85%$1.29B—7.40.4−17.5%
Median—7.40.4−17.5%